92 related articles for article (PubMed ID: 15588922)
1. Proceedings in uncovering the mechanism behind peroxisome proliferator-induced hepatocarcinogenesis.
Bosgra S; Mennes W; Seinen W
Toxicology; 2005 Jan; 206(3):309-23. PubMed ID: 15588922
[TBL] [Abstract][Full Text] [Related]
2. A cancer risk assessment of di(2-ethylhexyl)phthalate: application of the new U.S. EPA Risk Assessment Guidelines.
Doull J; Cattley R; Elcombe C; Lake BG; Swenberg J; Wilkinson C; Williams G; van Gemert M
Regul Toxicol Pharmacol; 1999 Jun; 29(3):327-57. PubMed ID: 10388618
[TBL] [Abstract][Full Text] [Related]
3. Rodent carcinogenicity of peroxisome proliferators and issues on human relevance.
Lai DY
J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2004 May; 22(1):37-55. PubMed ID: 15845221
[TBL] [Abstract][Full Text] [Related]
4. Human health risk assessment for peroxisome proliferators: more than 30 years of research.
Fidaleo M
Exp Toxicol Pathol; 2009 May; 61(3):215-21. PubMed ID: 18926675
[TBL] [Abstract][Full Text] [Related]
5. Peroxisome proliferators and receptor-mediated hepatic carcinogenesis.
Cattley RC
Toxicol Pathol; 2004; 32 Suppl 2():6-11. PubMed ID: 15503658
[TBL] [Abstract][Full Text] [Related]
6. Mechanistically-based human hazard assessment of peroxisome proliferator-induced hepatocarcinogenesis.
Ashby J; Brady A; Elcombe CR; Elliott BM; Ishmael J; Odum J; Tugwood JD; Kettle S; Purchase IF
Hum Exp Toxicol; 1994 Nov; 13 Suppl 2():S1-117. PubMed ID: 7857698
[TBL] [Abstract][Full Text] [Related]
7. Peroxisome proliferators: their biological and toxicological effects.
Dzhekova-Stojkova S; Bogdanska J; Stojkova Z
Clin Chem Lab Med; 2001 Jun; 39(6):468-74. PubMed ID: 11506454
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptor (PPAR) alpha-regulated growth responses and their importance to hepatocarcinogenesis.
James NH; Gill JH; Brindle R; Woodyatt NJ; Macdonald N; Rolfe M; Hasmall SC; Tugwood JD; Holden PR; Roberts RA
Toxicol Lett; 1998 Dec; 102-103():91-6. PubMed ID: 10022238
[TBL] [Abstract][Full Text] [Related]
9. Perturbation of rodent hepatocyte growth control by nongenotoxic hepatocarcinogens: mechanisms and lack of relevance for human health (review).
Chevalier S; Roberts RA
Oncol Rep; 1998; 5(6):1319-27. PubMed ID: 9769363
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferators: potential role of altered hepatocyte growth and differentiation in tumor development.
Cattley RC; Miller RT; Corton JC
Prog Clin Biol Res; 1995; 391():295-303. PubMed ID: 8532723
[TBL] [Abstract][Full Text] [Related]
11. [Peroxisome proliferation and possible cancer hazard].
Dybing E; Sanner T
Tidsskr Nor Laegeforen; 1995 Jun; 115(15):1839-41. PubMed ID: 7638833
[TBL] [Abstract][Full Text] [Related]
12. A reexamination of the PPAR-alpha activation mode of action as a basis for assessing human cancer risks of environmental contaminants.
Guyton KZ; Chiu WA; Bateson TF; Jinot J; Scott CS; Brown RC; Caldwell JC
Environ Health Perspect; 2009 Nov; 117(11):1664-72. PubMed ID: 20049115
[TBL] [Abstract][Full Text] [Related]
13. Are tumor incidence rates from chronic bioassays telling us what we need to know about carcinogens?
Gaylor DW
Regul Toxicol Pharmacol; 2005 Mar; 41(2):128-33. PubMed ID: 15698536
[TBL] [Abstract][Full Text] [Related]
14. Aging and enhanced hepatocarcinogenicity by peroxisome proliferator-activated receptor alpha agonists.
Youssef JA; Badr MZ
Ageing Res Rev; 2005 Jan; 4(1):103-18. PubMed ID: 15619473
[TBL] [Abstract][Full Text] [Related]
15. Peroxisome proliferator-activated receptors (PPARS) and carcinogenesis.
Vanden Heuvel JP
Toxicol Sci; 1999 Jan; 47(1):1-8. PubMed ID: 10048147
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.
Kirkland D; Aardema M; Henderson L; Müller L
Mutat Res; 2005 Jul; 584(1-2):1-256. PubMed ID: 15979392
[TBL] [Abstract][Full Text] [Related]
17. Using laser scanning cytometry to measure PPAR-mediated peroxisome proliferation and beta oxidation.
Pruimboom-Brees IM; Brees DJ; Shen AC; Keener M; Francone O; Amacher DE; Loy JK; Kerlin RL
Toxicol Pathol; 2005; 33(1):86-91. PubMed ID: 15805059
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferators: mechanisms of adverse effects in rodents and molecular basis for species differences.
Roberts RA
Arch Toxicol; 1999 Nov; 73(8-9):413-8. PubMed ID: 10650911
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor alpha-independent peroxisome proliferation.
Zhang X; Tanaka N; Nakajima T; Kamijo Y; Gonzalez FJ; Aoyama T
Biochem Biophys Res Commun; 2006 Aug; 346(4):1307-11. PubMed ID: 16806075
[TBL] [Abstract][Full Text] [Related]
20. Role of cytokines in non-genotoxic hepatocarcinogenesis: cause or effect?
Roberts RA; James NH; Cosulich S; Hasmall SC; Orphanides G
Toxicol Lett; 2001 Mar; 120(1-3):301-6. PubMed ID: 11323188
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
